Basic Information
Basic information for FTX-210-35aa
Peptide Name FTX-210-35aa
Genome Position chrX:74199951-74200055[-]
Species Human
Peptide Sequence MFIYAPIEGHLGCFQVLANINKAVINIHLQVFVLS
Peptide Length 35
Unique Yes
Grand Average of Hydropathicity 1.0543
Relative Molecular Mass 4526.19
Experimental Evidences no
lncRNA ID/Name ENSG00000230590;FTX
Transcript ID/Name ENST00000603037;FTX-210
Transcript Length 8347
Coding Ability 0.4725
DNA Sequence Corresponding to Peptide ATGTTTATCTATGCACCTATAGAGGGACATCTTGGTTGCTTCCAAGTTTTGGCCAATATTAATAAAGCTGTTATAAACATTCATTTGCAGGTTTTTGTGTTATCA
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :